Nature Medicine: COMPASS Pan-Cancer Model Predicts Immunotherapy Response
marinkazitnik · x · 2026-07-03
A Harvard Medical School team published a paper in Nature Medicine introducing COMPASS, a pan-cancer foundation model that predicts immune checkpoint inhibitor responses by analyzing tumor transcriptomes. While about a quarter of advanced cancer patients derive lasting benefits from immunotherapy, existing tools (like TMB and PD-L1 staining) lack reliability across different cancer types. COMPASS not only predicts durable responses across various cancers but also uncovers the specific biological mechanisms behind each prediction, holding the potential to significantly improve precision in immunotherapy selection for advanced cancer patients.
More from Research
- New paper: Absolute pose estimation from affine cues and gravity direction — ducha_aiki · 2026-09-11
- LoMa Paper Ships REALLY HardPairs Dataset, Accepted at ECCV 2026 — ducha_aiki · 2026-09-11
- Johns Hopkins Launches Full-Stack Hands-on Robot Learning Class with SO-101 Arm Kits — _krishna_murthy · 2026-09-11
- SyncWorld: In-Context Robot World Model Simulates Unseen Views and Embodiments Zero-Shot — ChongZzZhang · 2026-09-11
- A 3D Pose Dataset for Dogs Released — ducha_aiki · 2026-09-11
- Five tells that still make AI video read as AI, from physics glitches to missing operators — NewPhoneWhotiz · 2026-09-11